Related references
Note: Only part of the references are listed.CXCR4/CXCL12 Mediate Autocrine Cell- Cycle Progression in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
Wei Mo et al.
CELL (2013)
Rab25 Regulates Invasion and Metastasis in Head and Neck Cancer
Panomwat Amornphimoltham et al.
CLINICAL CANCER RESEARCH (2013)
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia
M. R. Janes et al.
LEUKEMIA (2013)
Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
Christian Posch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
mTOR Inhibition Prevents Epithelial Stem Cell Senescence and Protects from Radiation-Induced Mucositis
Ramiro Iglesias-Bartolome et al.
CELL STEM CELL (2012)
Dual mTORC1/2 and HER2 Blockade Results in Antitumor Activity in Preclinical Models of Breast Cancer Resistant to Anti-HER2 Therapy
Celina Garcia-Garcia et al.
CLINICAL CANCER RESEARCH (2012)
mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas
Alfredo A. Molinolo et al.
CLINICAL CANCER RESEARCH (2012)
Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells
Guang Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Translational Homeostasis via the mRNA Cap-Binding Protein, elF4E
Akiko Yanagiya et al.
MOLECULAR CELL (2012)
PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12
Xiaoqing Gan et al.
NATURE CELL BIOLOGY (2012)
Strategies for the discovery and development of therapies for metastatic breast cancer
Bedrich L. Eckhardt et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Decreased Lymphangiogenesis and Lymph Node Metastasis by mTOR Inhibition in Head and Neck Cancer
Vyomesh Patel et al.
CANCER RESEARCH (2011)
Discovery of 9-(6-Aminopyridin-3-yl)-1-(3-(trifluoromethyl)-phenyl)benzo[h][1,6]naphthyridin-2(1H)-one (Torin2) as a Potent, Selective, and Orally Available Mammalian Target of Raparnycin (mTOR) Inhibitor for Treatment of Cancer
Qingsong Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Selective activation of Akt1 by mammalian target of rapamycin complex 2 regulates cancer cell migration, invasion, and metastasis
E. K. Kim et al.
ONCOGENE (2011)
Differential regulation of the p73 cistrome by mammalian target of rapamycin reveals transcriptional programs of mesenchymal differentiation and tumorigenesis
Jennifer M. Rosenbluth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Spatial Coupling of mTOR and Autophagy Augments Secretory Phenotypes
Masako Narita et al.
SCIENCE (2011)
A Synthetic Biology Approach Reveals a CXCR4-G13-RhoSignaling Axis Driving Transendothelial Migration of Metastatic Breast Cancer Cells
Hiroshi Yagi et al.
SCIENCE SIGNALING (2011)
Homeostatic chemokine receptors and organ-specific metastasis
Albert Zlotnik et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells
Iskra Pusic et al.
CURRENT OPINION IN HEMATOLOGY (2010)
mTORC2 Regulates Neutrophil Chemotaxis in a cAMP- and RhoA-Dependent Fashion
Lunhua Liu et al.
DEVELOPMENTAL CELL (2010)
Rapamycin Inhibits Cytoskeleton Reorganization and Cell Motility by Suppressing RhoA Expression and Activity
Lei Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Identification of the Rac-GEF P-Rex1 as an Essential Mediator of ErbB Signaling in Breast Cancer
Maria Soledad Sosa et al.
MOLECULAR CELL (2010)
mToR signaling and drug development in cancer
Janet Dancey
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Tubers and tumors: rapamycin therapy for benign and malignant tumors
David R. Plas et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Somatic LKB1 Mutations Promote Cervical Cancer Progression
Shana N. Wingo et al.
PLOS ONE (2009)
Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction
Steven M. Devine et al.
BLOOD (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression
Giovanni Stallone et al.
TRANSPLANT INTERNATIONAL (2008)
P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration
Ivette Hernandez-Negrete et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer
Stephen G. Dann et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB
DD Sarbassov et al.
MOLECULAR CELL (2006)
Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist
HE Broxmeyer et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Sirolimus for Kaposi's sarcoma in renal-transplant recipients
G Stallone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Rapid mobilization of CD34+cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma
SM Devine et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma
MB Atkins et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD
AF Baas et al.
CELL (2004)
Chemokines: multiple levels of leukocyte migration control
B Moser et al.
TRENDS IN IMMUNOLOGY (2004)
Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton
DD Sarbassov et al.
CURRENT BIOLOGY (2004)
Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive
E Jacinto et al.
NATURE CELL BIOLOGY (2004)
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis
M Darash-Yahana et al.
FASEB JOURNAL (2004)
A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity
SG Martin et al.
NATURE (2003)
CXCRA is a major chemokine receptor on glioma cells and mediates their survival
Y Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
MTOR interacts with Raptor to form a nutrient-sensitive complex that signals to the cell growth machinery
DH Kim et al.
CELL (2002)
CXCR4/CXCL12 expression and signalling in kidney cancer
AJ Schrader et al.
BRITISH JOURNAL OF CANCER (2002)
Involvement of chemokine receptors in breast cancer metastasis
A Müller et al.
NATURE (2001)
Share Paper
